Saying Goodbye to Breast Cancer Faster

When a patient is at risk and testing for an illness, the results being returning in a timely fashion is of much importance. There is now a faster and cheaper sequencing that can now be used to detect the mutations in the genes of an illness. When a patient has breast cancer the first detection is commonly a tumor, and it can also be found to be caused by inheritance from the mutations of the gene BRCA1 or BRCA2. Prior to the currently new technology, when a patient used to get a gene sequence done after being diagnosed the results would take up to weeks or months before treatment can begin. The new technology now always the process to be much faster and the DNA can be sequenced in the DNA data copiously, and the patient can be more efficiently treated with the results. Overall the faster gene sequencing technology processing allows the doctors to identify certain mutations of the gene the patients with breast cancer carry before they begin treatments. Thus helping researchers conduct more treatment trials in a clinical setting to develop which treatments are ideal and beneficial for those identified particular mutations. So far, researchers have found chemotherapy drugs are concluded to be more efficient for the BRCA1 breast cancer due to its responsiveness to the therapy.

Article: http://www.medicalnewstoday.com/releases/274476.php
Related Article: http://www.medicalnewstoday.com/articles/264037.php